BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 38669767)

  • 1. Adipocyte-specific Nrf2 Deletion Negates Nitro-Oleic Acid Benefits on Glucose Tolerance in Diet-Induced Obesity.
    Chartoumpekis DV; Chen I; Salvatore SR; Schopfer FJ; Freeman BA; Khoo NKH
    Nitric Oxide; 2024 Jun; ():. PubMed ID: 38879114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermittent energy restriction inhibits tumor growth and enhances paclitaxel response in a transgenic mouse model of endometrial cancer.
    Zhao Z; Wang J; Kong W; Fang Z; Coleman M; Milne G; Burkett WC; Newton MA; Lee D; Deng B; Shen X; Suo H; Sun W; Hursting S; Zhou C; Bae-Jump VL
    bioRxiv; 2024 Feb; ():. PubMed ID: 38370796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weight Loss and/or Sulindac Mitigate Obesity-associated Transcriptome, Microbiome, and Protumor Effects in a Murine Model of Colon Cancer.
    Bowers LW; Glenny EM; Punjala A; Lanman NA; Goldbaum A; Himbert C; Montgomery SA; Yang P; Roper J; Ulrich CM; Dannenberg AJ; Coleman MF; Hursting SD
    Cancer Prev Res (Phila); 2022 Aug; 15(8):481-495. PubMed ID: 35653548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meal pattern alterations associated with intermittent fasting for weight loss are normalized after high-fat diet re-feeding.
    Gotthardt JD; Bello NT
    Physiol Behav; 2017 May; 174():49-56. PubMed ID: 28263771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent Fasting Promotes Fat Loss With Lean Mass Retention, Increased Hypothalamic Norepinephrine Content, and Increased Neuropeptide Y Gene Expression in Diet-Induced Obese Male Mice.
    Gotthardt JD; Verpeut JL; Yeomans BL; Yang JA; Yasrebi A; Roepke TA; Bello NT
    Endocrinology; 2016 Feb; 157(2):679-91. PubMed ID: 26653760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of obesity on breast cancer recurrence and minimal residual disease.
    Ecker BL; Lee JY; Sterner CJ; Solomon AC; Pant DK; Shen F; Peraza J; Vaught L; Mahendra S; Belka GK; Pan TC; Schmitz KH; Chodosh LA
    Breast Cancer Res; 2019 Mar; 21(1):41. PubMed ID: 30867005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermittent energy restriction inhibits tumor growth and enhances paclitaxel response in a transgenic mouse model of endometrial cancer.
    Zhao Z; Wang J; Kong W; Fang Z; Coleman MF; Milne GL; Burkett WC; Newton MA; Lara O; Lee D; Deng B; Shen X; Suo H; Sun W; Hursting SD; Zhou C; Bae-Jump VL
    Gynecol Oncol; 2024 Apr; 186():126-136. PubMed ID: 38669767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Could Intermittent Energy Restriction and Intermittent Fasting Reduce Rates of Cancer in Obese, Overweight, and Normal-Weight Subjects? A Summary of Evidence.
    Harvie MN; Howell T
    Adv Nutr; 2016 Jul; 7(4):690-705. PubMed ID: 27422504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Intermittent Energy Restriction Diet on Metabolic Profile and Weight Loss among Obese Adults.
    Stanek A; Brożyna-Tkaczyk K; Zolghadri S; Cholewka A; Myśliński W
    Nutrients; 2022 Apr; 14(7):. PubMed ID: 35406122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermittent energy restriction and weight loss: a systematic review.
    Davis CS; Clarke RE; Coulter SN; Rounsefell KN; Walker RE; Rauch CE; Huggins CE; Ryan L
    Eur J Clin Nutr; 2016 Mar; 70(3):292-9. PubMed ID: 26603882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Benefits and Harms of Intermittent Energy Restriction and Intermittent Fasting Amongst Obese, Overweight and Normal Weight Subjects-A Narrative Review of Human and Animal Evidence.
    Harvie M; Howell A
    Behav Sci (Basel); 2017 Jan; 7(1):. PubMed ID: 28106818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittent energy restriction vs. continuous energy restriction on cardiometabolic risk factors in patients with metabolic syndrome: a meta-analysis and systematic review.
    Xu R; Cao Y; Wang PY; Chen XL; Tao D
    Front Nutr; 2023; 10():1090792. PubMed ID: 37229479
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.